↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$350KSold on the market
1Companies
Sep 14, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 202616:00 | Sep 10, 2026 | AMLXAmylyx Pharmaceuticals, Inc. | Chief Financial Officer | S · Sell | $32.36 | −10,810 | 233,625 | -4% | −$350K | ||
| Aug 20, 202621:00 | Aug 18, 2026 | AMLXAmylyx Pharmaceuticals, Inc. | Chief Financial Officer | A · Grant | — | +22,807 | 244,435 | +10% | — |